1. Home
  2. IOVA vs THR Comparison

IOVA vs THR Comparison

Compare IOVA & THR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IOVA
  • THR
  • Stock Information
  • Founded
  • IOVA 2007
  • THR 1954
  • Country
  • IOVA United States
  • THR United States
  • Employees
  • IOVA N/A
  • THR N/A
  • Industry
  • IOVA Biotechnology: Biological Products (No Diagnostic Substances)
  • THR Industrial Machinery/Components
  • Sector
  • IOVA Health Care
  • THR Energy
  • Exchange
  • IOVA Nasdaq
  • THR Nasdaq
  • Market Cap
  • IOVA 975.1M
  • THR 878.9M
  • IPO Year
  • IOVA N/A
  • THR 2011
  • Fundamental
  • Price
  • IOVA $2.18
  • THR $26.50
  • Analyst Decision
  • IOVA Buy
  • THR
  • Analyst Count
  • IOVA 11
  • THR 0
  • Target Price
  • IOVA $11.90
  • THR N/A
  • AVG Volume (30 Days)
  • IOVA 9.8M
  • THR 241.1K
  • Earning Date
  • IOVA 11-06-2025
  • THR 11-06-2025
  • Dividend Yield
  • IOVA N/A
  • THR N/A
  • EPS Growth
  • IOVA N/A
  • THR 9.96
  • EPS
  • IOVA N/A
  • THR 1.58
  • Revenue
  • IOVA $241,525,000.00
  • THR $491,979,000.00
  • Revenue This Year
  • IOVA $68.14
  • THR $2.56
  • Revenue Next Year
  • IOVA $56.64
  • THR $6.31
  • P/E Ratio
  • IOVA N/A
  • THR $17.35
  • Revenue Growth
  • IOVA 636.99
  • THR N/A
  • 52 Week Low
  • IOVA $1.64
  • THR $23.05
  • 52 Week High
  • IOVA $12.51
  • THR $33.25
  • Technical
  • Relative Strength Index (RSI)
  • IOVA 46.63
  • THR 48.78
  • Support Level
  • IOVA $1.97
  • THR $26.27
  • Resistance Level
  • IOVA $2.38
  • THR $27.97
  • Average True Range (ATR)
  • IOVA 0.13
  • THR 0.78
  • MACD
  • IOVA 0.02
  • THR 0.03
  • Stochastic Oscillator
  • IOVA 48.78
  • THR 18.46

About IOVA Iovance Biotherapeutics Inc.

Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient. The company is preparing for potential U.S. regulatory approvals and commercialization of the first autologous T-cell therapy to address a solid tumor cancer. its objective is to be the leader in innovating, developing, and delivering tumor-infiltrating lymphocyte, or TIL, therapies for patients with solid tumor cancers.

About THR Thermon Group Holdings Inc.

Thermon Group Holdings Inc is a United States-based company that provides engineered industrial process heating solutions for process industries. It offers a full suite of products (heating units, electrode and gas-fired boilers, heating cables, industrial heating blankets and related products, temporary power solutions and tubing bundles), services (engineering, installation and maintenance services) and software (design optimization and wireless and network control systems) required to deliver comprehensive solutions to some of the world's Large and most complex projects. Its products and services include a wide range of electric heat tracing cables, steam heating solutions, controls, monitoring and software, instrumentation, project services, industrial heating and filtration solutions.

Share on Social Networks: